11.68

1.70% 0.19

Roivant Sciences Ltd (ROIV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ROIV Giù? Forum Previsione

Precedente Chiudi:

$11.49

Aprire:

$11.65

Volume 24 ore:

723.47K

Relative Volume:

0.12

Capitalizzazione di mercato:

$8.28B

Reddito:

$158.30M

Utile/perdita netta:

$4.74B

Rapporto P/E:

-8.7164

EPS:

-1.34

Flusso di cassa netto:

$-710.11M

1 W Prestazione:

+0.39%

1M Prestazione:

+0.56%

6M Prestazione:

+4.05%

1 anno Prestazione:

+35.24%

Intervallo 1D:

$11.62

$11.82

Intervallo di 1 settimana:

$11.04

$11.82

Portata 52W:

$8.611

$13.05

Roivant Sciences Ltd Stock (ROIV) Company Profile

Nome

Roivant Sciences Ltd

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

441-295-5950

Indirizzo

CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11

Dipendente

908

Cinguettio

Prossima data di guadagno

2024-11-12

Ultimi documenti SEC

ROIV's Discussions on Twitter

Confronta ROIV con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ROIV	11.67	8.28B	158.30M	4.74B	-710.11M	-1.34
VRTX	446.29	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	739.75	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	589.43	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	249.44	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.84	24.49B	3.30B	-501.07M	1.03B	11.54

Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-15	Iniziato	Wolfe Research	Outperform
2024-01-05	Iniziato	Piper Sandler	Overweight
2023-12-12	Iniziato	Deutsche Bank	Buy
2023-10-17	Iniziato	Guggenheim	Buy
2023-06-08	Iniziato	BofA Securities	Neutral
2022-10-27	Iniziato	JP Morgan	Overweight
2022-05-23	Iniziato	SVB Leerink	Outperform
2022-04-29	Iniziato	Cantor Fitzgerald	Overweight
2021-12-15	Iniziato	Goldman	Buy
2021-11-08	Iniziato	H.C. Wainwright	Buy
2021-10-28	Iniziato	Citigroup	Buy
2021-10-26	Iniziato	Cowen	Outperform
2021-10-26	Iniziato	Jefferies	Buy
2021-10-26	Iniziato	Truist	Buy

Mostra tutto

Roivant Sciences Ltd Borsa (ROIV) Ultime notizie

Nov 19, 2024

Roivant Sciences' (NASDAQ:ROIV) Shareholders Should Assess Earnings With Caution - Yahoo Finance

Nov 19, 2024

Nov 18, 2024

Principal Financial Group Inc. Trims Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Nov 18, 2024

Nov 15, 2024

Roivant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 14, 2024

Trump’s appointment of Ramaswamy sparks speculation on Korean biotech firms linked to Roivant - KBR

Nov 14, 2024

Nov 13, 2024

Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new "Department of Government Efficiency" (DOGE) - MSN

Nov 13, 2024

From Vadakkanchery to top US Govt post: Vivek Ramaswamy's Kerala roots - Mathrubhumi English

Nov 13, 2024

The Analyst Landscape: 5 Takes On Roivant Sciences - Benzinga

Nov 13, 2024

How Vivek Ramaswamy Became A Billionaire - Forbes

Nov 13, 2024

Who is Vivek Ramaswamy? What to know about Cincinnati billionaire part of Trump's Cabinet - The Cincinnati Enquirer

Nov 13, 2024

Vivek Ramaswamy Net Worth 2024: How He Built a Billion-Dollar Empire - Black Star News

Nov 13, 2024

Vivek Ramaswamy's journey from bright son of immigrants to being Donald Trump's pick - The Economic Times

Nov 13, 2024

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Vivek Ramaswamy Net Worth 2024: Salary, Net Worth in Rupees (INR), Annual Income, Houses, and Cars. - Jagran Josh

Nov 13, 2024

Who Is Vivek Ramaswamy, The Biotech Entrepreneur Now Part Of Trump 2.0 - NDTV

Nov 13, 2024

Vivek Ramaswamy Net Worth: How this key Trump aide built his billion-dollar empire - Moneycontrol

Nov 13, 2024

Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new 'Department of - The Times of India

Nov 13, 2024